Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric P Brass

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
The New England Journal of Medicine|August 9, 2013
Cardiovascular risks with azithromycinEric P Brass
Diabetes Spectrum : a Publication of the American Diabetes Association|August 7, 2015
The Food and Drug Administration and the Future of Drug Development for the Treatment of DiabetesEric P Brass
Clinical Pharmacology and Therapeutics|October 31, 2003
Label development and the label comprehension study for over-the-counter drugsEric P Brass, Michael Weintraub
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 22, 2015
Noninferiority Doesn't Mean Not InferiorBrad Spellberg, Eric P Brass
Journal of the American Geriatrics Society|March 3, 2011
Considerations in the development of drugs to treat sarcopeniaEric P Brass, Kathy E Sietsema
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 29, 2010
Should the guidelines for management of central venous catheters in patients with candidemia be changed now?Eric P Brass, John E Edwards
Vascular Medicine (London, England)|February 10, 2007
Review of mortality and cardiovascular event rates in patients enrolled in clinical trials for claudication therapiesEric P Brass, William R Hiatt
Pharmacological Reviews|June 25, 2009
Sixty years of Pharmacological Reviews: has the role of review articles in biomedical sciences changed and, if so, how does this affect Pharmacological Reviews?Eric P Brass, Ross D Feldman
The Canadian Journal of Cardiology|April 27, 2013
From bad behaviour to bad biology: pitfalls and promises in the management of resistant hypertensionRoss D Feldman, Eric P Brass
Journal of Clinical Pharmacology|September 13, 2011
Improving the FDA's advisory committee processEric P Brass, William R Hiatt
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
The New England Journal of Medicine|August 9, 2013
Cardiovascular risks with azithromycinEric P Brass
Diabetes Spectrum : a Publication of the American Diabetes Association|August 7, 2015
The Food and Drug Administration and the Future of Drug Development for the Treatment of DiabetesEric P Brass
Clinical Pharmacology and Therapeutics|October 31, 2003
Label development and the label comprehension study for over-the-counter drugsEric P Brass, Michael Weintraub
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 22, 2015
Noninferiority Doesn't Mean Not InferiorBrad Spellberg, Eric P Brass
Journal of the American Geriatrics Society|March 3, 2011
Considerations in the development of drugs to treat sarcopeniaEric P Brass, Kathy E Sietsema
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 29, 2010
Should the guidelines for management of central venous catheters in patients with candidemia be changed now?Eric P Brass, John E Edwards
Vascular Medicine (London, England)|February 10, 2007
Review of mortality and cardiovascular event rates in patients enrolled in clinical trials for claudication therapiesEric P Brass, William R Hiatt
Pharmacological Reviews|June 25, 2009
Sixty years of Pharmacological Reviews: has the role of review articles in biomedical sciences changed and, if so, how does this affect Pharmacological Reviews?Eric P Brass, Ross D Feldman
The Canadian Journal of Cardiology|April 27, 2013
From bad behaviour to bad biology: pitfalls and promises in the management of resistant hypertensionRoss D Feldman, Eric P Brass
Journal of Clinical Pharmacology|September 13, 2011
Improving the FDA's advisory committee processEric P Brass, William R Hiatt
Pageof 8